Evidence map›Paper›PMID 27696114›Full record

ArticleMolecular neurobiology2017

Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat.

Marcos Roberto de Oliveira, Alessandra Peres, Clarissa Severino Gama, Simone Morelo Dal Bosco

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Analysis of the Phenolic Profile ofInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Resveratrol and Brain Mitochondria: a Review.Molecular neurobiology · 2018
    Review
  17. Pinocembrin Suppresses HMolecular neurobiology · 2018
    Article
  18. Review
  19. Article
  20. Naringenin Attenuates HNeurochemical research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Marcos Roberto de OliveiraDepartment of Chemistry/ICET, Federal University of Mato Grosso (UFMT), Av. Fernando Corrêa da Costa, 2367, Cuiaba, MT, 78060-900, Brazil. mrobioq@gmail.com.
Alessandra PeresHealth Basic Sciences Department, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
Clarissa Severino GamaLaboratório de Psiquiatria Molecular, Instituto Nacional de Ciência e Tecnologia-Medicina Translacional (INCT-TM), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Simone Morelo Dal BoscoFederal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
Universidade Federal de Ciências da Saúde de Porto Alegre · BRUniversidade Federal de Mato Grosso · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

CNPq Bolsista Produtividade
6 · The paper itself

Abstract

Pinocembrin (PB; 5,7-dihydroxyflavanone; C

Indexed as

Cell Line, TumorCell SurvivalCytochromes cDown-RegulationFlavanonesHumansMAP Kinase Signaling SystemMembrane Potential, MitochondrialMitochondriaNeuroblastomaNeuronsNeuroprotective AgentsNF-E2-Related Factor 2ParaquatCytochromes cFlavanonesNeuroprotective AgentsNFE2L2 protein, humanNF-E2-Related Factor 2ParaquatpinocembrinAntioxidantMitochondriaNrf2ParaquatPinocembrin

Identifiers

PMID27696114
OpenAlexW2526973717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.